Literature DB >> 10351189

Health-related quality-of-life measurement in patients with Parkinson's disease.

C Jenkinson1, R Fitzpatrick, V Peto.   

Abstract

Outcome measures are increasingly used to assess the impact of diseases such as Parkinson's disease (PD) from the patient's perspective. These measures, in the form of questionnaires to assess health-related quality of life (HR-QOL), are of 2 main kinds: generic and disease-specific. The former is intended to be relevant to the widest range of health problems; the latter is developed specifically to assess HR-QOL for a specific condition. Possible consequences of PD have been assessed by generic instruments such as the Sickness Impact Profile (SIP), the Nottingham Health Profile (NHP), the Medical Outcomes Study 36-Item Short Form (SF-36) Health Survey and also by disease-specific instruments; in particular, the Parkinson's Disease Quality-of-Life Questionnaire (PDQL) and 39-Item Parkinson's Disease Questionnaire (PDQ-39). This article summarises the criteria whereby such instruments should be evaluated by potential users and describes in more detail the methods of developing and testing such disease-specific instruments for use in PD. There is a range of valid and feasible methods available for taking into account patients' views of PD outcomes. These will become important outcome measures in future clinical trials of treatment regimes.

Entities:  

Mesh:

Year:  1999        PMID: 10351189     DOI: 10.2165/00019053-199915020-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  33 in total

1.  Parkinson's disease: disability, review, and management.

Authors:  W J Mutch; A Strudwick; S K Roy; A W Downie
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

2.  The health burdens of Parkinson's disease.

Authors:  E A Chrischilles; L M Rubenstein; M D Voelker; R B Wallace; R L Rodnitzky
Journal:  Mov Disord       Date:  1998-05       Impact factor: 10.338

3.  A methodological framework for assessing health indices.

Authors:  B Kirshner; G Guyatt
Journal:  J Chronic Dis       Date:  1985

4.  Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39)

Authors:  C Jenkinson; V Peto; R Fitzpatrick; R Greenhall; N Hyman
Journal:  Age Ageing       Date:  1995-11       Impact factor: 10.668

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Quality of life in patients with Parkinson's disease: development of a questionnaire.

Authors:  A G de Boer; W Wijker; J D Speelman; J C de Haes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

7.  A randomized study of the efficacy of the PROPATH Program for patients with Parkinson disease.

Authors:  B S Mercer
Journal:  Arch Neurol       Date:  1996-09

8.  Parkinson's disease in the district of the Northampton Health Authority, United Kingdom. A study of prevalence and disability.

Authors:  R L Sutcliffe; R Prior; B Mawby; W J McQuillan
Journal:  Acta Neurol Scand       Date:  1985-10       Impact factor: 3.209

9.  What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life.

Authors:  A Bowling
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

10.  Depression in Parkinson's disease: a quantitative and qualitative analysis.

Authors:  A M Gotham; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

View more
  11 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Turkish Version Study of "Parkinson's Disease Quality of Life Questionnaire" (PDQL).

Authors:  Elif Elçin Dereli; Ayşe Yaliman; Tuğba Kuru Çolaka; Aycan Çakmak; Arzu Razak Özdinçler; Şule Badilli Demirbaş
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

Review 3.  Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials.

Authors:  I Côté; J P Grégoire; J Moisan
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

Review 4.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson's Disease Questionnaire (PDQ-39).

Authors:  Hui-Ing Ma; Wen-Juh Hwang; Mei-Jin Chen-Sea
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

6.  Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study.

Authors:  D J Brooks; H Sagar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

7.  Two questionnaires for Parkinson's disease: are the PDQ-39 and PDQL equivalent?

Authors:  Pablo Martinez-Martin; Marcos Serrano-Dueñas; Maria João Forjaz; Maria Soledad Serrano
Journal:  Qual Life Res       Date:  2007-05-30       Impact factor: 4.147

8.  Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39).

Authors:  Ulle Krikmann; Pille Taba; Taavi Lai; Toomas Asser
Journal:  Health Qual Life Outcomes       Date:  2008-03-25       Impact factor: 3.186

9.  Determinants of generic and specific health-related quality of life in patients with Parkinson's disease.

Authors:  Xiao-Jing Tu; Wen-Juh Hwang; Hui-Ing Ma; Ling-Hui Chang; Shih-Pin Hsu
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

10.  SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures.

Authors:  Carlos A Brown; Eric M Cheng; Ron D Hays; Stefanie D Vassar; Barbara G Vickrey
Journal:  Qual Life Res       Date:  2009-08-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.